Skip to main content
Erschienen in:

27.01.2022 | Gynecologic Oncology

“Clock mapping” prior to excisional surgery in vulvar Paget’s disease: tailoring the surgical plan

verfasst von: Giorgia Garganese, Luigi Pedone Anchora, Simona Maria Fragomeni, Giulia Mantovani, Angela Santoro, Stefano Gentileschi, Giacomo Corrado, Andrea Lombisani, Valentina Lancellotta, Luca Tagliaferri, Gian Franco Zannoni, Giovanni Scambia, Frediano Inzani

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 2/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Paget disease is a rare neoplasm of the skin that mainly involves the vulvar region. Vulvar Paget’s disease (VPD) can spread beyond the apparent edges of the lesion resulting in a high risk of involved surgical margins. Our aim is to verify the efficacy of a preoperative vulvo-vaginal intensive clock mapping in the prediction of the invasiveness and the extension of VPD.

Materials and methods

All consecutive patients with primary VPD referred to our institution from July 2005 to December 2018 were subjected to a preoperative intensive biopsy mapping (clock mapping) of the vulvo-vaginal area: inside and outside the vulvar skin visible lesion, according to o’clock positions, and in the vagina. Patients with positive biopsies “only inside” or “also beyond” the visible lesion were included, respectively, in Group A and B. Surgical excision was drawn passing by the points with negative histology. Pathological findings of mapping biopsies were compared with those from radical surgery.

Results

A total of 28 women were enrolled. After clock mapping definitive histology: 17 (60.7%) and 11 (39.3%) patients were included in Group A and B. Definitive histology showed non-invasive, micro-invasive and invasive VPD, respectively, in 13 (46.4%), 11 (39.3%) and 4 (14.3%) patients, with 4 patients further upstaged. Overall, negative margins were found in 14 (50%) patients: 9 (32.1%) from Group A and 5 (17.9%) from Group B. In 23 cases (82.1%), clock mapping identified free surgical margins along the vulvo-perineal skin excision front.

Conclusions

Preoperative clock mapping emerged as potentially useful workup tool to predict invasiveness and extension of VPD, to tailor surgical excision.
Literatur
1.
Zurück zum Zitat Kurman RJ, Carcangiu ML, Herrington CS (2014) Tumors of the vulva. In: (IARC) International Agency for Research on Cancer (eds) WHO classification of tumours of female reproductive organs, 4th edn. World Health Organization, Lyon, France, pp 236–237 Kurman RJ, Carcangiu ML, Herrington CS (2014) Tumors of the vulva. In: (IARC) International Agency for Research on Cancer (eds) WHO classification of tumours of female reproductive organs, 4th edn. World Health Organization, Lyon, France, pp 236–237
2.
Zurück zum Zitat Delport ES (2013) Extramammary Paget’s disease of the vulva: an annotated review of the current literature. Australas J Dermatol 54:9–21CrossRef Delport ES (2013) Extramammary Paget’s disease of the vulva: an annotated review of the current literature. Australas J Dermatol 54:9–21CrossRef
3.
Zurück zum Zitat Van Der Linden M, Meeuwis KA, Bulten J et al (2016) Paget disease of the vulva. Crit Rev Oncol Hematol 101:60–74CrossRef Van Der Linden M, Meeuwis KA, Bulten J et al (2016) Paget disease of the vulva. Crit Rev Oncol Hematol 101:60–74CrossRef
4.
Zurück zum Zitat Hatta N, Yamada M, Hirano T et al (2008) Extramammary Paget’s disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol 158:313–318PubMed Hatta N, Yamada M, Hirano T et al (2008) Extramammary Paget’s disease: treatment, prognostic factors and outcome in 76 patients. Br J Dermatol 158:313–318PubMed
5.
Zurück zum Zitat Lavoué V, Lemarrec A, Bertheuil N, Henno S, Mesbah H, Watier E, Levêque J, Morcel K (2013) Quality of life and female sexual function after skinning vulvectomy with split-thickness skin graft in women with vulvar intraepithelial neoplasia or vulvar Paget disease. Eur J Surg Oncol 39(12):1444–1450CrossRef Lavoué V, Lemarrec A, Bertheuil N, Henno S, Mesbah H, Watier E, Levêque J, Morcel K (2013) Quality of life and female sexual function after skinning vulvectomy with split-thickness skin graft in women with vulvar intraepithelial neoplasia or vulvar Paget disease. Eur J Surg Oncol 39(12):1444–1450CrossRef
6.
Zurück zum Zitat Edey KA, Allan E, Murdoch JB, Cooper S, Bryant A (2013) Interventions for the treatment of Paget’s disease of the vulva. Cochrane Database Syst Rev 10:CD0009245 Edey KA, Allan E, Murdoch JB, Cooper S, Bryant A (2013) Interventions for the treatment of Paget’s disease of the vulva. Cochrane Database Syst Rev 10:CD0009245
7.
Zurück zum Zitat MacLean AB, Makwana M, Ellis PE, Cunnington F (2004) The management of Paget’s disease of the vulva. J Obstet Gynaecol 24(2):124–128CrossRef MacLean AB, Makwana M, Ellis PE, Cunnington F (2004) The management of Paget’s disease of the vulva. J Obstet Gynaecol 24(2):124–128CrossRef
8.
Zurück zum Zitat Qi Y, Hu J, Sun C et al (2014) Extramammary Paget’s disease: analysis of 17 Chinese cases. Indian J Dermatol Venereol Leprol 80:129–133CrossRef Qi Y, Hu J, Sun C et al (2014) Extramammary Paget’s disease: analysis of 17 Chinese cases. Indian J Dermatol Venereol Leprol 80:129–133CrossRef
9.
Zurück zum Zitat Borghi C, Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Scaffa C, Perotto S, Leone Roberti Maggiore U, Recalcati D, Lorusso D, Raspagliesi F (2018) Invasive Paget disease of the vulva. Int J Gynecol Cancer 28(1):176–182CrossRef Borghi C, Bogani G, Ditto A, Martinelli F, Signorelli M, Chiappa V, Scaffa C, Perotto S, Leone Roberti Maggiore U, Recalcati D, Lorusso D, Raspagliesi F (2018) Invasive Paget disease of the vulva. Int J Gynecol Cancer 28(1):176–182CrossRef
10.
Zurück zum Zitat Garganese G, Inzani F, Mantovani G, Santoro A, Valente M, Babini G, Petruzzellis G, Fragomeni SM, Gentileschi S, Bove S, Franchi M, Angelico G, Fagotti A, Scambia G, Zannoni GF (2019) The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget's disease. J Cancer Res Clin Oncol 145(9):2211–2225. https://doi.org/10.1007/s00432-019-02975-3. Epub 2019 Jul 11CrossRefPubMed Garganese G, Inzani F, Mantovani G, Santoro A, Valente M, Babini G, Petruzzellis G, Fragomeni SM, Gentileschi S, Bove S, Franchi M, Angelico G, Fagotti A, Scambia G, Zannoni GF (2019) The vulvar immunohistochemical panel (VIP) project: molecular profiles of vulvar Paget's disease. J Cancer Res Clin Oncol 145(9):2211–2225. https://​doi.​org/​10.​1007/​s00432-019-02975-3. Epub 2019 Jul 11CrossRefPubMed
11.
Zurück zum Zitat Kodama S, Kaneko T, Saito M, Yoshiya N, Honma S, Tanaka K (1995) A clinicopathologic study of 30 patients with Paget’s disease of the vulva. Gynaecol Oncol 56:63–70CrossRef Kodama S, Kaneko T, Saito M, Yoshiya N, Honma S, Tanaka K (1995) A clinicopathologic study of 30 patients with Paget’s disease of the vulva. Gynaecol Oncol 56:63–70CrossRef
12.
Zurück zum Zitat Fishman DA, Chambers SK, Schwartz PE, Kohorn EI, Chambers JT (1995) Extramammary Paget’s disease of the vulva. Gynecol Oncol 56:266–270CrossRef Fishman DA, Chambers SK, Schwartz PE, Kohorn EI, Chambers JT (1995) Extramammary Paget’s disease of the vulva. Gynecol Oncol 56:266–270CrossRef
14.
Zurück zum Zitat Parker LP, Parker JR, Bodurka-Bevers D, Deavers M, Bevers MW, Shen-Gunther J et al (2000) Paget’s disease of the vulva: pathology, pattern of involvement, and prognosis. Gynecol Oncol 77(1):183–189CrossRef Parker LP, Parker JR, Bodurka-Bevers D, Deavers M, Bevers MW, Shen-Gunther J et al (2000) Paget’s disease of the vulva: pathology, pattern of involvement, and prognosis. Gynecol Oncol 77(1):183–189CrossRef
15.
Zurück zum Zitat Tebes S, Cardosi R, Hoffman M (2002) Paget’s disease of the vulva. Am J Obstet Gynecol 187(2):281–283 (discussion 283–284)CrossRef Tebes S, Cardosi R, Hoffman M (2002) Paget’s disease of the vulva. Am J Obstet Gynecol 187(2):281–283 (discussion 283–284)CrossRef
16.
Zurück zum Zitat Black D, Tornos C, Soslow RA, Awtrey CS, Barakat RR, Chi DS (2007) The outcomes of patients with positive margins after excision for intraepithelial Paget’s disease of the vulva. Gynecol Oncol 104(3):547–550CrossRef Black D, Tornos C, Soslow RA, Awtrey CS, Barakat RR, Chi DS (2007) The outcomes of patients with positive margins after excision for intraepithelial Paget’s disease of the vulva. Gynecol Oncol 104(3):547–550CrossRef
17.
Zurück zum Zitat Jones ISC, Crandon A, Sanday K (2011) Paget’s disease of the vulva: Diagnosis and follow-up key to management; a retrospective study of 50 cases from Queensland. Gynecol Oncol 122(1):42–44CrossRef Jones ISC, Crandon A, Sanday K (2011) Paget’s disease of the vulva: Diagnosis and follow-up key to management; a retrospective study of 50 cases from Queensland. Gynecol Oncol 122(1):42–44CrossRef
18.
Zurück zum Zitat Mendivil AA, Abaid L, Epstein HD, Rettenmaier MA, Brown JV, Micha JP et al (2012) Paget’s disease of the vulva: a clinicopathologic institutional review. Int J Clin Oncol 17(6):569–574CrossRef Mendivil AA, Abaid L, Epstein HD, Rettenmaier MA, Brown JV, Micha JP et al (2012) Paget’s disease of the vulva: a clinicopathologic institutional review. Int J Clin Oncol 17(6):569–574CrossRef
19.
Zurück zum Zitat Cai Y, Sheng W, Xiang L, Wu X, Yang H (2013) Primary extramammary Paget’s disease of the vulva: the clinicopathological features and treatment outcomes in a series of 43 patients. Gynecol Oncol 129(2):412–416CrossRef Cai Y, Sheng W, Xiang L, Wu X, Yang H (2013) Primary extramammary Paget’s disease of the vulva: the clinicopathological features and treatment outcomes in a series of 43 patients. Gynecol Oncol 129(2):412–416CrossRef
20.
Zurück zum Zitat Iacoponi S, Zalewski K, Fruscio R, Diaz-De la Noval B, De Iaco P, Ceccaroni M et al (2016) Prognostic factors for recurrence and survival among patients with invasive vulvar Paget disease included in the VULCAN study. Int J Gynaecol Obstet 133(1):76–79CrossRef Iacoponi S, Zalewski K, Fruscio R, Diaz-De la Noval B, De Iaco P, Ceccaroni M et al (2016) Prognostic factors for recurrence and survival among patients with invasive vulvar Paget disease included in the VULCAN study. Int J Gynaecol Obstet 133(1):76–79CrossRef
21.
Zurück zum Zitat Onaiwu CO, Salcedo MP, Pessini SA, Munsell MF, Euscher EE, Reed KE et al (2017) Paget’s disease of the vulva: a review of 89 cases. Gynecol Oncol Rep 19:46–49CrossRef Onaiwu CO, Salcedo MP, Pessini SA, Munsell MF, Euscher EE, Reed KE et al (2017) Paget’s disease of the vulva: a review of 89 cases. Gynecol Oncol Rep 19:46–49CrossRef
25.
Zurück zum Zitat Tagliaferri L, Casà C, Macchia G, Pesce A, Garganese G, Gui B et al (2018) The role of radiotherapy in extramammary Paget disease: a systematic review. Int J Gynecol Cancer 28(4):829–839CrossRef Tagliaferri L, Casà C, Macchia G, Pesce A, Garganese G, Gui B et al (2018) The role of radiotherapy in extramammary Paget disease: a systematic review. Int J Gynecol Cancer 28(4):829–839CrossRef
Metadaten
Titel
“Clock mapping” prior to excisional surgery in vulvar Paget’s disease: tailoring the surgical plan
verfasst von
Giorgia Garganese
Luigi Pedone Anchora
Simona Maria Fragomeni
Giulia Mantovani
Angela Santoro
Stefano Gentileschi
Giacomo Corrado
Andrea Lombisani
Valentina Lancellotta
Luca Tagliaferri
Gian Franco Zannoni
Giovanni Scambia
Frediano Inzani
Publikationsdatum
27.01.2022
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 2/2022
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-022-06408-4

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Einer von sieben Frauen macht die Menopause sehr zu schaffen

Von mäßigen bis schweren vasomotorischen Beschwerden sind 14,7% der Frauen in der Postmenopause betroffen. Das haben kanadische Forscherinnen in einer Subgruppenanalyse der WARM-Studie herausgefunden.

Die elektronische Patientenakte kommt: Das sollten Sie jetzt wissen

Am 15. Januar geht die „ePA für alle“ zunächst in den Modellregionen an den Start. Doch schon bald soll sie in allen Praxen zum Einsatz kommen. Was ist jetzt zu tun? Was müssen Sie wissen? Wir geben in einem FAQ Antworten auf 21 Fragen.

Keine eingeschränkten Kassenleistungen bei Schwangerschaft nach IVF

Nach privat bezahlter In-vitro-Fertilisation muss die gesetzliche Krankenkasse ein Arzneimittel zum Erhalt der Schwangerschaft bezahlen, so ein Urteil des Sozialgerichts in München.

Medikamente verändern wohl Nährstoffzusammensetzung der Muttermilch

Einige Medikamente wie selektive Serotonin-Wiederaufnahmehemmer können offenbar die Makronährstoffzusammensetzung der Muttermilch verändern. Das birgt möglicherweise gesundheitliche Risiken für manche gestillte Kinder.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.